🔗 Share this article

Treasury head Reeves has revealed she is preparing "targeted action to deal with household expense challenges" in the forthcoming financial statement.

In comments to the BBC, she noted that lowering price rises is a shared duty of both the administration and the central bank.

The United Kingdom's inflation rate is forecast to be the most elevated among the Group of Seven developed nations this calendar year and the following year.

Potential Energy Bill Measures

Sources suggest the government could intervene to bring down utility costs, for example by reducing the present 5% rate of value-added tax charged on energy supplies.

A further approach is to cut some of the government charges presently added to household expenses.

Budgetary Constraints and Analyst Predictions

The government will receive the latest assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much space there is for such actions.

The consensus from the majority of experts is that the Chancellor will have to introduce higher taxes or expenditure reductions in order to fulfill her self-imposed fiscal targets.

Earlier on Thursday, estimates showed there was a twenty-two billion pound gap for the chancellor to resolve, which is at the lower end of projections.

"It is a joint task between the Bank of England and the government to bear down further on some of the drivers of price increases," Reeves told reporters in the US capital, at the conferences of the International Monetary Fund and World Bank.

Tax Pledges and Global Concerns

While a great deal of the attention has been on probable tax rises, the Treasury chief said the most recent data from the fiscal watchdog had not altered her commitment to election pledges not to raise tax levels on earnings tax, VAT or social security contributions.

She attributed an "uncertain global environment" with rising geopolitical and trade tensions for the Budget tax moves, likely to be focused on those "with the broadest shoulders."

International Trade Tensions

Commenting on apprehensions about the United Kingdom's economic relations with China she said: "The UK's security interests always come first."

Last week's declaration by China to increase export controls on rare earths and other materials that are key for high-technology production led US President Donald Trump to threaten an additional 100% tariff on goods from the Asian country, increasing the risk of an all-out commercial conflict between the two global powers.

The US Treasury Secretary called the Chinese action "commercial pressure" and "a global supply chain control attempt."

Inquired about considering the American proposal to join its conflict with the Asian nation, Reeves said she was "extremely troubled" by China's actions and urged the Beijing authorities "to avoid restrictions and limit trade."

She said the action was "harmful for the global economy and generates additional obstacles."

"I believe there are fields where we should confront Chinese policies, but there are also important opportunities to export to Chinese markets, including financial services and other areas of the economy. We've got to maintain that equilibrium right."

The Treasury chief also stated she was collaborating with other major economies "on our own critical minerals approach, so that we are reduced dependence."

Health Service Medicine Costs and Funding

The Chancellor also admitted that the cost the National Health Service spends on pharmaceuticals could increase as a result of ongoing negotiations with the Trump administration and its pharmaceutical firms, in return for reduced taxes and funding.

A number of the biggest global drug companies have said in recent statements that they are either delaying or scrapping investments in the UK, with several attributing the insufficient payments they are obtaining.

Recently, the Science Minister said the cost the health service pays for drugs would need to increase to stop businesses and pharmaceutical investment leaving the UK.

The Chancellor informed media: "It has been observed as a result of the pricing regime, that drug testing, new drugs have not been available in the United Kingdom in the manner that they are in other EU nations."

"The objective is to make sure that individuals receiving care from the NHS are can receive the top critical treatments in the world. And so we are reviewing these issues, and... seeking to secure increased capital into Britain."